Polymerase chain reaction detection of melanoma cells in the circulation: Relation to clinical stage, surgical treatment, and recurrence from melanoma

Journal of Clinical Oncology

Volumn 16, Issue 5, 1998, Pages 1760-1769

  Curry, Benjamin J ^a   Myers, Kieda ^a   Hersey, Peter ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOMA ANTIGEN; MONOPHENOL MONOOXYGENASE; TUMOR MARKER;

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; MELANOMA CELL; METASTASIS; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031832837     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.5.1760     Document Type: Article

References (25)

1. Balch CM, Soong S-J, Shaw HM, et al.: An analysis of prognostic factors in 8500 patients with cutaneous melanoma, in Balch CM, Houghton AN, Milton GW, et al.(eds): Cutaneous Melanoma (ed 2). Philadelphia, PA, Lippincott, 1992,pp 165-180
2. Hart IR, Saini A: Biology of tumour metastasis. Lancet 339:1453-1457,1992
3. Reinigen D, Cruse C, Wells K, et al.: The evaluation of putative tumor markers for malignant melanoma. Ann Plast Surg 28:55-59, 1992
4. Buzaid A, Sandler A, Hayden C, et al.: Neuron-specific enolase as a tumor marker in metastatic melanoma. Am J Clin Oncol 17:430-431, 1994
5. Buzaid A, Sandler A, Hayden C, et al.: Correlation of lipidassociated sialic acid and tumor burden in melanoma. Int J Biol Markers 9:247-250,1994
6. von Schoultz E, Hansson LO, Djureen E, et al.: Prognostic value of serum analyses of S-100 protein in malignant melanoma. Melanoma Res 6:133-137, 1996
7. Buzaid AC, Balch CM: Polymerase chain reaction for detection of melanoma in peripheral blood: Too early to assess clinical value. J Natl Cancer Inst 88:569-570,1996
8. Smith B, Selby P, Southgate J, et al.: Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338:1227-1229, 1991
9. Curry BJ, Smith MJ, Hersey P: Detection and quantitation of melanoma cells in the circulation of patients. Melanoma Res 6:45-54,1996
10. Brossait P, Keilholz U, Willhauck M, et al.: Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 101:887-889,1993
11. Battayani Z, Grob JJ, Xerri L, et al.: Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 131:443-447, 1995
12. Foss AJ, Guille MJ, Occleston NL, et al.: The detection of melanoma cells in peripheral blood by reverse-transcription-polymerase chain reaction. BrJ Cancer 72:155-159,1995
13. Hoon DS, Wang Y, Dale PS, et al.: Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13:2109-2116,1995
14. Kunter U, Euer J, Probst M, et al.: Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 88:590-594,1996
15. Tobal K, Sherman LS, Foss AIE, et al.: Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction. Invest Ophthalmol Vis Sei 34:2622-2625,1993
16. Van der Velde-Zimmermann D, Roijers JFM, BouwensRombouts A, et al.: Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. Am J Pathol 149:759-764,1996
17. Mellado B, Colomer D, Castel T, et al.: Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: Association with clinical stage and prognosis. J Clin Oncol 14:2091-2097,1996
18. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sei USA 74:5463-5467, 1977
19. Adema GJ, de Boer AJ, Vogel AM, et al.: Molecular characterization of the melanocytic lineage-specific antigen gp100. J Biol Chem 269:20126-20133,1994
20. Brouwenstijn N, Slager EH, Bakker ABH, et al.: Transcription of the gene encoding melanoma-associated antigen gp100 in tissues and cell lines other than those of the melanocytic lineage. Br J Cancer 76:1562-1566,1997
21. Sers C, Riethmuller G, Johnson JP: MUC18, a melanomaprogression associated molecule, and its potential role in tumor vascularization and hematogenous spread. Cancer Res 54:5689-5694, 1994
22. Brown JP, Woodbury RG, Hart CE, et al.: Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc Natl Acad Sei USA 78:539-543,1981
23. Coulie PG, Brichard V, Van Pel A, et al.: A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 180:35-42,1994
24. Reinhold U, Ludtke-Handjery HC, Schnautz S, et al.: The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression. J Invest Dermatol 108:166-169,1997
25. Kirkwood JM, Strawderman MH, Emstoff MS, et al.: Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 14:7-17,1996